A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 1, 2008, Pages 28-33

  Abedin, Asiya ^a   Mohammed, Imran ^a   Hopkinson, Andrew ^a   Dua, Harminder S ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; BETA DEFENSIN; POLYPEPTIDE ANTIBIOTIC AGENT; RNA; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; DEFB 109 PEPTIDE, HUMAN; DEFB-109 PEPTIDE, HUMAN; MESSENGER RNA; UNCLASSIFIED DRUG;

ACANTHAMOEBA INFECTION; ARTICLE; BACTERIAL INFECTION; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; CYTOLOGY; DEFB 109 GENE; DRY EYE; EYE INFECTION; EYE INFLAMMATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION; ACANTHAMOEBA KERATITIS; AGAR GEL ELECTROPHORESIS; BIOSYNTHESIS; GENETICS; INFLAMMATION; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

ACANTHAMOEBA KERATITIS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BASE SEQUENCE; BETA-DEFENSINS; CONJUNCTIVA; CORNEA; DRY EYE SYNDROMES; ELECTROPHORESIS, AGAR GEL; EYE INFECTIONS; GENE EXPRESSION; HUMANS; INFLAMMATION; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 39549109127     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0645     Document Type: Article

References (39)

1. Cullor JS, Mannis MJ, Murphy CJ, Smith WL, Selsted ME, Reid TW. In vitro antimicrobial activity of defensins against ocular pathogens. Arch Ophthalmol. 1990;108:861-864.
2. McDermott AM, Rich D, Cullor J, et al. The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears. Br J Ophthalmol. 2006;90:609-611.
3. Kagan BL, Ganz T, Lehrer RI. Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology. 1994;87:131-149.
4. Weinberg A, Krisanaprakornkit S, Dale BA. Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med. 1998;9:399-414.
5. Tosi MF. Innate immune responses to infection. J Allergy Clin Immunol. 116:241-249, 2005; quiz 250.
6. Yang D, Biragyn A, Kwak LW, Oppenheim JJ. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 2002;23:291-296.
7. Oppenheim JJ, Biragyn A, Kwak LW, Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis. 2003;62(Suppl 2):ii17-ii21.
8. Huang LC, Petkova TD, Reins RY, Proske RJ, McDermott AM. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci. 2006;47:2369-2380.
9. Yamagata M, Rook SL, Sassa Y, et al. Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects. FASEB J. 2006;20:2058-2067.
10. Zhou L, Huang LQ, Beuerman RW, et al. Proteomic analysis of human tears: defensin expression after ocular surface surgery. J Proteome Res. 2004;3:410-416.
11. Ohgami K, Ilieva IB, Shiratori K, et al. Effect of human cationic antimicrobial protein 18 peptide on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 2003;44:4412-4418.
12. Narayanan S, Miller WL, McDermott AM. Expression of human β-defensins in conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci. 2003;44:3795-3801.
13. Yasin B, Wang W, Pang M, et al. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol. 2004;78:5147-5156.
14. McCray PB Jr, Bentley L. Human airway epithelia express a beta-defensin. Am J Respir. 1997;16:343-349.
15. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest. 1998;101:1633-1642.
16. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature. 1997;387:861.
17. Haynes RJ, Tighe PJ, Dua HS. Innate defence of the eye by antimicrobial defensin peptides. Lancet. 1998;352:451-452.
18. Haynes RJ, Tighe PJ, Dua HS. Antimicrobial defensin peptides of the human ocular surface. Br J Ophthalmol. 1999;83:737-741.
19. Haynes RJ, McElveen JE, Dua HS, Tighe PJ, Liversidge J. Expression of human beta-defensins in intraocular tissues. Invest Ophthalmol Vis Sci. 2000;41:3026-3031.
20. McIntosh RS, Cade JE, Al-Abed M, et al. The spectrum of antimicrobial peptide expression at the ocular surface. Invest Ophthalmol Vis Sci. 2005;46:1379-1385.
21. Sousa LB, Mannis MJ, Schwab IR, et al. The use of synthetic Cecropin (D5C) in disinfecting contact lens solutions. CLAO J. 1996;22:114-117.
22. Schwab IR, Dries D, Cullor J, et al. Corneal storage medium preservation with defensins. Cornea. 1992;11:370-375.
23. Gallo RL, Murakami M, Ohtake T, Zaiou M. Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol. 2002;110:823-831.
24. Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest. 2002;109:693-697.
25. McDermott AM. Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf. 2004;2:229-247.
26. Jin Y, Hammer J, Pate M, et al. Antimicrobial activities and structures of two linear cationic peptide families with various amphipathic beta-sheet and alpha-helical potentials. Antimicrob Agents Chemother. 2005;49:4957-4964.
27. Hopkinson A, McIntosh RS, Tighe PJ, James DK, Dua HS. Amniotic membrane for ocular surface reconstruction: donor variations and the effect of handling on TGF-beta content. Invest Ophthalmol Vis Sci. 2006;47:4316-4322.
28. Boyum A. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77-89.
29. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
30. Hancock RE. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis. 2001;1:156-164.
31. Egbert PR, Lauber S, Maurice DM. A simple conjunctival biopsy. Am J Ophthalmol. 1977;84:798-801.
32. Connor CG, Campbell JB, Tirey WW, Steel SA, Burke JH. Modification of impression cytology for in-office use. J Am Optom Assoc. 1991;62:898-901.
33. Singh R, Joseph A, Umapathy T, Tint NL, Dua HS. Impression cytology of the ocular surface. Br J Ophthalmol. 2005;89:1655-1659.
34. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res. 1996;6:995-1001.
35. Premratanachai P, Joly S, Johnson GK, McCray PB Jr, Jia HP, Guthmiller JM. Expression and regulation of novel human beta-defensins in gingival keratinocytes. Oral Microbiol Immunol. 2004;19:111-117.
36. Islam D, Bandholtz L, Nilsson J, et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med. 2001;7:180-185.
37. Nakamura T, Furunaka H, Miyata T, et al. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus): isolation and chemical structure. J Biol Chem. 1988;263:16709-16713.
38. Milner SM, Ortega MR. Reduced antimicrobial peptide expression in human burn wounds. Burns. 1999;25:411-413.
39. Bishop JL, Finlay BB. Friend or foe? - antimicrobial peptides trigger pathogen virulence. Trends Mol Med. 2006;12:3-6.